lobbying_activities: 1556109

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
1556109	8f22a3f2-d6b6-448a-a55b-0e3ff44c27fe	Q2	AMERICAN PHARMACISTS ASSOCIATION	3071	AMERICAN PHARMACISTS ASSOCIATION	2014	second_quarter	PHA	HCR(PL 111-152/111-148); Medicare Part D; Medication Therapy Management; Medicare Part B; reimbursement for pharmacist services; Social Security Act; transitions of care; risk evaluation and mitigation services; prescription drug monitoring program; prescription drug abuse; hydrocodone; track and trace/supply chain; ACOs; immunization; HIT; compounding; Sustainable Growth Rate; FDASIA(PL 112-144); tele-medicine; Medicare fraud, waste and abuse; quality rating; AMP FUL's	Centers For Disease Control & Prevention (CDC),Centers For Medicare and Medicaid Services (CMS),Drug Enforcement Administration (DEA),Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,SENATE			0	0	2014-07-17T14:14:10.763000-04:00